Compare SaaS Products

Granza Bio is a biotechnology company developing a novel delivery "shell" platform to direct therapeutic cargo to specific tissues. Their proprietary delivery vehicles are designed using non-immunogenic proteins equipped with a targeting receptor, achieving targeted tropism to organs of interest. These vehicles offer higher stability than conventional lipid nanoparticles (LNPs) and can encompass a variety of cargo, including proteins, DNA, and RNA. For their lead candidate, Granza Bio is leveraging the discovery of the immune system's powerful suite of weapons, "attack particles". Utilizing their advanced delivery platform, they aim to target these "attack particles" against a range of diseases such as cancer, autoimmune disorders, and infections. Interested to know more? Get in touch [email protected]!

We’re building the AI copilot for radiologists, powered by a foundational model for medical imaging. RadMate AI will read radiology images and generate full reports for radiologists to review and submit. Mohamed and Adam are technical co-founders who met while studying Computer Science at Cornell University. Before starting RadMate AI to solve the problems his dad faced as a radiologist, Adam worked at Palantir on the initial launch of Palantir’s Al Platform. Mohamed has experience at AWS, where his goal was to help enterprises innovate on the cloud, and PathAl, where he worked on their image viewer platform to improve the workflow of pathologists.